New medication for treatment resistant depression added to PBS
Published
A new nasal spray treatment for depression has been added to the Pharmaceutical Benefits Scheme. The drug called esketamine is the first new depression medication to be subsidised by the federal government in 30 years. But experts say more needs to be done to increase accessibility.
Sign up now for daily news from Australia and around the world. You can also subscribe to Insight's weekly newsletter for in-depth features and first-person stories.